However, the percentage of CD8+/CD3+ cells was relatively higher in the GC-peri-tumor (72.6 ± 16.2%) than in the GC-body samples (61.2 ± 14.4%) (p = 0.057). The gene discussed is CD8A; the disease is gastric cancer.